Boston Scientific to pay $30M over heart devices
In 2010, similar allegations led Boston Scientific to plead guilty to two misdemeanor charges of withholding information from the U.S. Food and Drug Administration and to agree to pay $296 million in fines.
Boston Scientific, which bought Guidant for $27 billion in 2006, did not immediately respond to a request for comment.
James Allen, a patient who received one of the devices and who initially brought the civil suit under the anti-fraud False Claims Act, will receive $2.25 million as a whistleblower, the department said.
Subscribe for FREE!
Union Leader Business Newsletter
Exeter drug sweep nets four
Win tickets to see Medium Lauren Rainbow
Wreaths Across America get big send-off
Where is Benghazi? Kuster's refusal to stand
Bird blenders: 'Green energy' sacrifice
Anderson lewdness trial is delayed